WILMINGTON, DE, UNITED STATES, December 21, 2024 /EINPresswire / -- The fecal immunochemical diagnostic test market has become a vital part of global efforts to detect and prevent colorectal ...

A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method ...

DiaCarta Inc., a precision molecular diagnostic company, has announced the publication of its prospective clinical trial data on its blood-based test for triaging FIT (fecal immunochemical ...

Fecal Immunochemical Diagnostic Test (FIT) Market The FIT market is growing due to increased awareness and adoption of non-invasive colorectal cancer screening options. WILMINGTON, DE, UNITED STATES,.

Jochim S Terhaar sive Droste; Sietze T van Turenhout; Frank A Oort; René WM van der Hulst; Vincent A Steeman; Usha Coblijn; Lisette van der Eem; Ruud Duijkers; Anneke A Bouman; Gerrit A Meijer ...

In the present study, test accuracy of one of the most commonly used FITs was evaluated in a large cohort of asymptomatic, high-risk individuals undergoing colonoscopy surveillance. It was found ...

A colonoscopy is a procedure used to allow a doctor to view and directly image the inside of a patient's large intestine.

Lowering the positivity threshold for a high-quality fecal immunochemical test (FIT) can increase sensitivity of noninvasive screening for colorectal cancer in a more economical way.

The US Preventive Services Task Force recommends that all adults aged 45 to 75 years be screened for CRC, which can include both colonoscopy and stool tests like the fecal immunochemical test (FIT ...

Health and research company, Care Access, is making its Heart & Kidney Health Screening initiative available to residents of Mobile, Ala. This health screening raises awareness and provides testing ...